These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4447983)

  • 1. [Effect of essential phospholipids on the galactosamine hepatitis in rats].
    Petzold H; Titlbach O
    Cesk Gastroenterol Vyz; 1974 Apr; 28(3):178-80. PubMed ID: 4447983
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of fasting on galactosamine induced hepatitis in experimental animals.
    Pickering RW
    Arzneimittelforschung; 1977; 27(10):1992-6. PubMed ID: 579109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relations between phospholipid composition of plasma and liver microsomes in experimental cholestasis and hepatitis].
    Gallenkamp H; Brachtel D; Richter E
    Verh Dtsch Ges Inn Med; 1973; 79():930-3. PubMed ID: 4790046
    [No Abstract]   [Full Text] [Related]  

  • 4. [Incorporation of 14-C-Glycine during galactosamine hepatitis of young and old rats (author's transl)a*].
    Platt D; Förster L; Förster K
    Aktuelle Gerontol; 1976 Jul; 6(7):319-27. PubMed ID: 14537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ["Galactosamine refractory" regenerating liver--a model for studies on the etiology mechanism of galactosamine hepatitis].
    Reutter W; Bauer C; Bachmann W; Lesch R
    Hoppe Seylers Z Physiol Chem; 1972 May; 353(5):747. PubMed ID: 5069316
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of d-galactosamine hydrochloride on lipids and their fatty acid composition in plasma and liver of guinea pigs.
    Gallenkamp H; Bartsch GG; Löhr JP; Brachtel D; Richter E
    Acta Hepatogastroenterol (Stuttg); 1976 Feb; 23(1):3-9. PubMed ID: 1258600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of preliminary fasting on the development of D-galactosamine-induced acute lesion of the liver in rats].
    Adzharov D; Donchev N; Kerimova M; Naĭdenova E; Borov B
    Biull Eksp Biol Med; 1989 Jan; 107(1):33-6. PubMed ID: 2914170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Status of the antioxidant, monooxygenase and humoral immune system of the body in d-galactosamine hepatitis].
    Korda MM
    Ukr Biokhim Zh (1978); 1996; 68(1):72-5. PubMed ID: 8755105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Behavior of 125-I-fibrinogen and 131-I-albumin in experimental galactosamine hepatitis].
    von Mahn I; Merkel H; Sattler EL; Müller-Berghaus G
    Verh Dtsch Ges Inn Med; 1974; 80():437-9. PubMed ID: 4454578
    [No Abstract]   [Full Text] [Related]  

  • 10. [Primary and secondary liver response to D-galactosamine administration in galactosamine hepatitis].
    Reutter W; Bauer C; Bachman W; Lesch R
    Verh Dtsch Ges Inn Med; 1973; 79():927-30. PubMed ID: 4790045
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of partial hepatectomy on the hepatotoxicity of D-galactosamine.
    Andreicuţ S; Kerekes M
    Morphol Embryol (Bucur); 1982; 28(2):177-84. PubMed ID: 6213854
    [No Abstract]   [Full Text] [Related]  

  • 12. [The incorporation of essential phospholipids into the organs of intact and galactosamine intoxicated rats].
    Lekim D; Betzing H
    Arzneimittelforschung; 1974 Aug; 24(8):1217-21. PubMed ID: 4479326
    [No Abstract]   [Full Text] [Related]  

  • 13. Microsomal drug metabolism in acute and chronic galactosamine induced hepatic injuries.
    Shigeta Y
    Gastroenterol Jpn; 1977; 12(6):435-45. PubMed ID: 608565
    [No Abstract]   [Full Text] [Related]  

  • 14. [Specific hepatotoxic effect of D-galactosamine].
    Andreicut S; Kerekes M
    Morphol Embryol (Bucur); 1977; 23(3):221-5. PubMed ID: 142915
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lipid metabolism and liver function in D-galactosamine poisoning in rats].
    Vengerovskiĭ AI; Saratikov AS
    Patol Fiziol Eksp Ter; 1988; (3):52-5. PubMed ID: 3174253
    [No Abstract]   [Full Text] [Related]  

  • 16. [Significance of enzyme activity in pyrimidine biosynthesis for the development of galactosamine liver lesions].
    Pausch J; Keppler D; Decker K
    Verh Dtsch Ges Inn Med; 1972; 78():1375-7. PubMed ID: 4665550
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings: Subcellular distribution of phospholipids in rare-earth induced liver damage.
    von Lehmann V; Oberdisse E
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R56. PubMed ID: 4276600
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhanced D-galactosamine hepatotoxicity after propylthiouracil treatment in the rat.
    Mihas TA; Ceballos R; Hirschowitz BI; Gibson RG; Mihas AA
    J Med; 1982; 13(1-2):71-9. PubMed ID: 6956652
    [No Abstract]   [Full Text] [Related]  

  • 19. [Galactosamine-hepatitis and anit-cholestasis. Liver damage caused by D-galactosamine-hydrochloride and 1-naphthyl-isothiocyanate (anit)].
    Leinweber B
    Fortschr Med; 1973 Jun; 91(18):792-6. PubMed ID: 4723864
    [No Abstract]   [Full Text] [Related]  

  • 20. [Galactosamine hepatitis: injury to the plasma membrane of hepatic cells following administration of D-galactosamine].
    Reutter W; Bachmann W
    Verh Dtsch Ges Inn Med; 1971; 77():1177-8. PubMed ID: 5155984
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.